KAUST researchers refute challenges to targeted cancer therapy

Drugs that inhibit a key protein should offer new targeted cancer therapy for leukemia and breast cancer.

ADC startup raises €30M; Cyrus Biotechnology to spin out Levitate Bio

Plus, news about ProKidney: ADC makers return with new startup: Adcytherix raised €30 million ($32.1 million) in a seed round to … Sign up to

June 12, 2024

Opinion | Gonorrhea, Then and Now

Claire Panosian Dunavan is a professor of medicine and infectious diseases at the David Geffen School of Medicine at UCLA and a past-president of the

December 23, 2023

Dementia Tied to Physical Inactivity; Migraine in the ED; Human Brain Project Ends

At least one in 15 dementia cases may be attributable to physical inactivity, a meta-analysis suggested. (Alzheimer’s & Dementia) Intermittent fasting recovered sleep and activity

August 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.